LINDA HADOUS: Open Payments
NPI 1649733965 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 12 payments from 9 companies in 2025. Trend: 2023 $992 · 2024 $301 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 1 | $104 |
| Novo Nordisk Inc | 1 | $83 |
| BSN Medical Inc | 1 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| VivaQuant Inc, dba Rhythm Express | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: PYRUKYND, Ozempic, JOBST SPORT, MOUNJARO, ABILIFY MAINTENA, CAPLYTA, REXULTI, RHYTHM EXPRESS.
Industry payments across MI — which companies pay providers there.
